• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Omnicell, Fresenius Kabi collaborate on controlled substance dispensers

November 10, 2021 By Sean Whooley

Omnicell Fresenius kabiOmnicell (NSDQ:OMCL) and Fresenius Kabi announced today that they are collaborating on new technology for managing controlled substances.

The collaboration aims to provide U.S. hospitals and health systems with innovative new pharmacy technology designed to support safety and efficiency in dispensing controlled substances in patient care areas.

Omnicell designs a controlled substance dispenser (CSD) for high-volume, automated single-dose dispensing that helps pharmacies better manage controlled substances, reduce diversion and save nursing time. The design for one dose at a time aims to eliminate the need for countbacks and decrease the time required to resolve discrepancies, giving nurses more time for direct patient care.

The company designed new cassettes for the CSD specifically for Fresenius Kabi’s Simplist MicroVault prefilled syringes to offer more flexibility with medication supply chain and enhanced controlled substance management initiatives. Omnicell CSD will accommodate MicroVault for a range of low-dose narcotic medications, including morphine, hydromorphone and fentanyl.

Fresenius Kabi’s syringes are manufacturer-prepared in the U.S. with a 24-month shelf life.

“Omnicell is committed to addressing the biggest challenges in pharmacy care delivery through technology,” Omnicell VP of Product Management for Point-of-Care Solutions Nish Parekh said in a news release. “Through innovative collaborations with healthcare leaders like Fresenius Kabi, we’re delivering the solutions designed to help our customers manage controlled substances, reduce diversion, optimize inventory, and enhance clinical workflows to support optimal care and patient safety.”

The companies said their relationship and offering represents a step toward the vision of the “Autonomous Pharmacy,” a plan to develop a zero-error, fully automated medication management infrastructure.

“Fresenius Kabi is committed to medication safety and the responsible use of controlled substances,” Fresenius Kabi USA VP of Marketing Angie Lindsey said. “The combination of Omnicell’s Controlled Substance Dispenser automation workflow with Fresenius Kabi Simplist MicroVault prefilled syringes will offer healthcare providers advanced tools and technology to achieve these aims.”

Filed Under: Auto-injectors, Business/Financial News, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: freseniuskabi, Omnicell

IN CASE YOU MISSED IT

  • BD’s IV catheters plant in Utah marks 70 years
  • Novo taps Nanexa for long-acting obesity injectables with €1.17B pact
  • Abbott partners with Berry Street to add nutrition coaching to Lingo
  • Dexcom CFO to expand into COO role
  • Beta Bionics insulin patch pump scores FDA clearance

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS